Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pathophysiology-Guided Therapy for Sleep Apnea in the Elderly
NCT02703220Phase 4Recruiting
- Sponsor
- VA Office of Research & Development
- Start
- Jul 2015
- Primary completion
- Jul 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in sleep apnea comparing Hyperoxia, Acetazolamide (ACZ) and Finasteride (3 arms). Primary endpoints: Apneic threshold, Cerebrovascular responsiveness to carbon-dioxide at 7 days and 2 more. Started Jul 2015; status: recruiting.
02
Drugs
acetazolamidefinasterideoxygen
03
Conditions
sleep apnea
Beyond the preview
Go deeper on NCT02703220.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02703220.